{
    "clinical_study": {
        "@rank": "73783", 
        "arm_group": {
            "arm_group_label": "Single Arm", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of the study is to collect additional safety and efficacy information on the\n      Lutonix (formerly Moxy) Drug Coated Balloon for treatment of stenosis or occlusion of the\n      femoral and popliteal arteries"
        }, 
        "brief_title": "LEVANT 2 Safety Registry", 
        "completion_date": {
            "#text": "September 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Peripheral Artery Disease", 
        "condition_browse": {
            "mesh_term": "Peripheral Arterial Disease"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or non-pregnant female \u2265 18 years of age\n\n          -  Rutherford Clinical Category 2-4\n\n          -  Patient is willing to provide informed consent, is geographically stable and comply\n             with the required follow up visits, testing schedule and medication regimen\n\n          -  Length \u2264 15 cm\n\n          -  Up to two focal lesions or segments within the designated 15 cm length\n\n          -  \u2265 70% stenosis by visual estimate\n\n          -  de novo lesion(s) or non-stented restenotic lesion(s) > 90 days from prior\n             angioplasty procedure\n\n          -  Target vessel diameter between \u2265 4 and \u2264 6 mm\n\n          -  Successful, uncomplicated (without use of a crossing device) antegrade wire crossing\n             of lesion\n\n          -  No other prior vascular interventions within 2 weeks before and/or planned 30 days\n             after the protocol treatment\n\n        Exclusion Criteria:\n\n          -  Pregnant or planning on becoming pregnant or men intending to father children; Life\n             expectancy of < 5 years\n\n          -  Patient is currently participating in an investigational drug or other device study\n             or previously enrolled in this study\n\n          -  History of hemorrhagic stroke within 3 months\n\n          -  Renal failure or chronic kidney disease\n\n          -  Inability to take required study medications or allergy to contrast that cannot be\n             adequately managed with pre- and post-procedure medication\n\n          -  Anticipated use of IIb/IIIa inhibitor prior to randomization\n\n          -  Sudden symptom onset, acute vessel occlusion, or acute or sub-acute thrombus in\n             target vessel\n\n          -  Use of adjunctive treatment modalities (i.e. laser, atherectomy, cryoplasty,\n             scoring/cutting balloon, etc.)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01790243", 
            "org_study_id": "CL0006-03"
        }, 
        "intervention": {
            "arm_group_label": "Single Arm", 
            "intervention_name": "Lutonix Drug Coated Balloon", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 22, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Fremont", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94538"
                    }, 
                    "name": "Mission Cardiovascular Research Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saginaw", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48604"
                    }, 
                    "name": "Mid-Michigan Heart and Vascular Center, P.C."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wyoming", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "49519"
                    }, 
                    "name": "Metro Health Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Jackson", 
                        "country": "United States", 
                        "state": "Mississippi", 
                        "zip": "39216"
                    }, 
                    "name": "Jackson Heart Clinic/St. Dominic's Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Springfield", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "65804"
                    }, 
                    "name": "Mercy Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Teaneck", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07666"
                    }, 
                    "name": "Holy Name Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10021"
                    }, 
                    "name": "New York Presbyterian Hospital/Weill Cornell Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45220"
                    }, 
                    "name": "Good Samaritan Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Braunfels", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78130"
                    }, 
                    "name": "Mission Research Institute"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Multicenter, Registry of the Lutonix Drug Coated Balloon for Treatment of Femoropopliteal Arteries (LEVANT 2 Safety Registry)", 
        "overall_official": {
            "affiliation": "Massachusetts General Hospital", 
            "last_name": "Kenneth Rosenfield, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Unanticipated device- or drug- related adverse events", 
            "safety_issue": "Yes", 
            "time_frame": "60 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01790243"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Freedom from death, amputation or limb reintervention; Composite of freedom from all-cause perioperative death.", 
            "measure": "Safety", 
            "safety_issue": "No", 
            "time_frame": "1, 6, 12, 24, 36, 48, 60"
        }, 
        "source": "C. R. Bard", 
        "sponsors": {
            "collaborator": {
                "agency": "Bard Ltd", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "C. R. Bard", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}